Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Advancements to Engineer Mesenchymal Stem Cells and Their Extracellular Vesicles for Targeting and Destroying Tumors Publisher Pubmed



Karami Fath M1 ; Moayedi Banan Z2 ; Barati R3 ; Mohammadrezakhani O4 ; Ghaderi A5 ; Hatami A6 ; Ghiabi S7 ; Zeidi N8 ; Asgari K9 ; Payandeh Z10 ; Barati G11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
  2. 2. School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Faculty of Pharmacy, Ramsar Campus, Mazandaran University of Medical Sciences, Sari, Iran
  5. 5. Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  7. 7. Department of Medical Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  8. 8. Division of Pharmaceutical Science, Long Island University, Brooklyn, NY, United States
  9. 9. Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  10. 10. Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden
  11. 11. Stem Cell Technology Research Center, Tehran, Iran

Source: Progress in Biophysics and Molecular Biology Published:2023


Abstract

Mesenchymal stem cells (MSCs) have the ability to migrate into tumor sites and release growth factors to modulate the tumor microenvironment. MSC therapy have shown a dual role in cancers, promoting or inhibiting. However, MSCs could be used as a carrier of anticancer agents for targeted tumor therapy. Recent technical improvements also allow engineering MSCs to improve tumor-targeting properties, protect anticancer agents, and decrease the cytotoxicity of drugs. While some of MSC functions are mediated through their secretome, MSCs-derived extracellular vesicles (EVs) are also proposed as a possible viechle for cancer therapy. EVs allow efficient loading of anticancer agents and have an intrinsic ability to target tumor cells, making them suitable for targeted therapy of tumors. In addition, the specificity and selectivity of EVs to the tumor sites could be enhanced by surface modification. In this review, we addressed the current approaches used for engineering MSCs and EVs to effectively target tumor sites and deliver anticancer agents. © 2023 Elsevier Ltd
Related Docs
View other Related Docs
1. The Therapeutic Effect of Mscs and Their Extracellular Vesicles on Neuroblastoma, Progress in Biophysics and Molecular Biology (2024)
2. Mesenchymal Stem Cell-Released Oncolytic Virus: An Innovative Strategy for Cancer Treatment, Cell Communication and Signaling (2023)
3. Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents, Current Medicinal Chemistry (2016)
4. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
5. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
6. Mesenchymal Stem Cells: A New Platform for Targeting Suicide Genes in Cancer, Journal of Cellular Physiology (2018)
7. The Role of Mirnas From Mesenchymal Stem/Stromal Cells-Derived Extracellular Vesicles in Neurological Disorders, Human Cell (2023)
8. Human Wharton's Jelly Mesenchymal Stem Cells-Derived Secretome Could Inhibit Breast Cancer Growth in Vitro and in Vivo, Iranian Journal of Basic Medical Sciences (2020)
Experts (# of related papers)
View all Related Experts
Shaghayegh Haghjooy Javanmard (12)
Rasoul Salehi (7)
Other Related Docs
9. Msc-Derived Exosomes Enhance the Anticancer Activity of Drugs in 3D Spheroid of Breast Cancer Cells, Journal of Drug Delivery Science and Technology (2024)
10. Emerging Role of Mesenchymal Stem/Stromal Cells (Mscs) and Mscs-Derived Exosomes in Bone- and Joint-Associated Musculoskeletal Disorders: A New Frontier, European Journal of Medical Research (2023)
11. Oncolytic Newcastle Disease Virus Delivered by Mesenchymal Stem Cells-Engineered System Enhances the Therapeutic Effects Altering Tumor Microenvironment, Virology Journal (2020)
12. Therapeutic Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles’ Mirnas on Retinal Regeneration: A Review, Stem Cell Research and Therapy (2021)
13. Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy, Immunological Investigations (2020)
14. An Anticancer Effect of Umbilical Cord-Derived Mesenchymal Stem Cell Secretome on the Breast Cancer Cell Line, Cell and Tissue Banking (2019)
15. Microrna-100 Shuttled by Mesenchymal Stem Cell-Derived Exosomes Suppresses in Vitro Angiogenesis Through Modulating the Mtor/Hif-1Α/Vegf Signaling Axis in Breast Cancer Cells, Cellular Oncology (2017)
16. Dual Protective and Cytotoxic Benefits of Mesenchymal Stem Cell Therapy in Combination With Chemotherapy/Radiotherapy for Cancer Patients, Critical Reviews in Eukaryotic Gene Expression (2015)
17. Pathological Role of Inflammation in Ocular Disease Progress and Its Targeting by Mesenchymal Stem Cells (Mscs) and Their Exosome; Current Status and Prospect, Pathology Research and Practice (2023)
18. The Therapeutic Potential of Human Umbilical Cord Mesenchymal Stromal Cells Derived Exosomes for Wound Healing: Harnessing Exosomes As a Cell-Free Therapy, Journal of Stem Cells and Regenerative Medicine (2024)
19. Phic31/Piggybac Modified Stromal Stem Cells: Effect of Interferon Γ And/Or Tumor Necrosis Factor (Tnf)-Related Apoptosis-Inducing Ligand (Trail) on Murine Melanoma, Molecular Cancer (2014)
20. Early Diagnosis of Breast and Ovarian Cancers by Body Fluids Circulating Tumor-Derived Exosomes, Cancer Cell International (2020)
21. Genetically Modified Murine Adipose-Derived Mesenchymal Stem Cells Producing Interleukin-2 Favor B16f10 Melanoma Cell Proliferation, Immunological Investigations (2015)
22. The Role of Extracellular Vesicles and Microparticles in Central Nervous System Disorders: Mechanisms, Biomarkers, and Therapeutic Potential, Cellular and Molecular Neurobiology (2024)
23. Effect of Human Wharton's Jelly Mesenchymal Stem Cell Secretome on Proliferation, Apoptosis and Drug Resistance of Lung Cancer Cells, Research in Pharmaceutical Sciences (2015)
24. Pomegranate Seed Extract Enhances the Inhibitory Effect of Adipose- Derived Mesenchymal Stem Cells on Breast Cancer Cell Line in Co-Culture Conditions, Research in Pharmaceutical Sciences (2022)
25. Human Mesenchymal Stromal Cell Therapy for Prevention and Recovery of Chemo/Radiotherapy Adverse Reactions, Cytotherapy (2015)
26. Combination Therapy of Stem Cell-Derived Exosomes and Biomaterials in the Wound Healing, Stem Cell Reviews and Reports (2022)
27. Exploring the Role of Exosomes in Diabetic Neuropathy: From Molecular Mechanisms to Therapeutic Potential, Biomedicine and Pharmacotherapy (2025)
28. Combination Therapy of Metadichol Nanogel and Lipocalin-2 Engineered Mesenchymal Stem Cells Improve Wound Healing in Rat Model of Excision Injury, Advanced Pharmaceutical Bulletin (2022)
29. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
30. Recent Progress in Cancer Immunotherapy: Application of Nano-Therapeutic Systems, Journal of Drug Delivery Science and Technology (2024)
31. In Vitro Assessment of Cytokine Expression Profile of Mcf-7 Cells in Response to Hwj-Mscs Secretome, Advanced Pharmaceutical Bulletin (2019)
32. Pi3k/Akt/Mtor Signaling Pathway Modulation by Circular Rnas in Breast Cancer Progression, Pathology Research and Practice (2023)
33. Dendrimers As Nanoscale Vectors: Unlocking the Bars of Cancer Therapy, Seminars in Cancer Biology (2022)
34. The Therapeutic Potential of Human Adipose-Derived Mesenchymal Stem Cells Producing Cxcl10 in a Mouse Melanoma Lung Metastasis Model, Cancer Letters (2018)
35. Cancer Stem Cells (Cscs): The Blockage of Metastatic and Stemness Properties by Metal Nanoparticles, Nanomedicine Research Journal (2021)
36. Engineered Small Extracellular Vesicles As a Novel Platform to Suppress Human Oncovirus-Associated Cancers, Infectious Agents and Cancer (2023)
37. Oncolytic Virus Delivery Modulated Immune Responses Toward Cancer Therapy: Challenges and Perspectives, International Immunopharmacology (2022)
38. Unveiling Mesenchymal Stem Cells’ Regenerative Potential in Clinical Applications: Insights in Mirna and Lncrna Implications, Cells (2023)
39. Advances in Targeted Nano-Delivery of Bevacizumab Using Nanoparticles: Current Insights, Innovations, and Future Perspectives, Journal of Drug Delivery Science and Technology (2024)
40. Blockage of Hotair Reduced Cell Proliferation in Human Ovarian Cancer Cells Through Upregulation of Akt2, Indian Journal of Gynecologic Oncology (2019)
41. Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line, Iranian Journal of Pharmaceutical Research (2019)
42. Immune Evader Cancer Stem Cells Direct the Perspective Approaches to Cancer Immunotherapy, Stem Cell Research and Therapy (2022)
43. Exosomes As Therapeutic and Drug Delivery Vehicle for Neurodegenerative Diseases, Journal of Nanobiotechnology (2024)
44. Cancer Exosomes and Natural Killer Cells Dysfunction: Biological Roles, Clinical Significance and Implications for Immunotherapy, Molecular Cancer (2022)
45. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
46. Immobilized Nanoparticles-Mediated Enzyme Therapy; Promising Way Into Clinical Development, Discover Nano (2023)
47. Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes As a Cell-Free Therapy Approach for the Treatment of Skin, Bone, and Cartilage Defects, Connective Tissue Research (2022)
48. Lxr Inhibitor Sr9243-Loaded Immunoliposomes Modulate Lipid Metabolism and Stemness in Colorectal Cancer Cells, Medical Oncology (2023)
49. The Roles of Tumor-Derived Exosomes in Altered Differentiation, Maturation and Function of Dendritic Cells, Molecular Cancer (2021)
50. Mesenchymal Stem/Stromal (Mscs)-Derived Exosome Inhibits Retinoblastoma Y-79 Cell Line Proliferation and Induces Their Apoptosis, Nanomedicine Research Journal (2022)